Clinical trial testing CBD on probes Bupropion and Warfarin

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  260314

• Contact name

  Firas Almazedi

• Contact email

  firas.almazedi@fortrea.com

• Sponsor organisation

  Publication of this data is currently deferred.

• Eudract number

  2019-000164-22

• Clinicaltrials.gov Identifier

  19/NE/0039, REC

• Duration of Study in the UK

  0 years, 3 months, 19 days

• Research summary

  Publication of this data is currently deferred.

• REC name

  North East - York Research Ethics Committee

• REC reference

  19/NE/0039

• Date of REC Opinion

  30 Apr 2019

• REC opinion

  Further Information Favourable Opinion